Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Type 2 Diabetes Mellitus.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01646320
What this trial is testing

Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 320
Testing effectiveness (Phase 2)Study completedNCT01756703
What this trial is testing

Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria

Who this might be right for
Diabetic Nephropathy
Tanabe Pharma Corporation 67
Testing effectiveness (Phase 2)Study completedNCT01240759
What this trial is testing

Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy

Who this might be right for
Type 2 Diabetes Mellitus
Shionogi 218
Large-scale testing (Phase 3)Study completedNCT02630706
What this trial is testing

Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 506
Post-approval studies (Phase 4)Study completedNCT02147925
What this trial is testing

Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects

Who this might be right for
Non-alcoholic Fatty Liver Disease
Sun Yat-sen University 75
Not applicableStudy completedNCT01778738
What this trial is testing

Type 2 Diabetes After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: A Randomised Single Centre Study

Who this might be right for
Type 2 DiabetesMorbid Obesity
Sykehuset i Vestfold HF 125
Early research (Phase 1)Study completedNCT03638778
What this trial is testing

Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 105
Not applicableEnded earlyNCT05168306
What this trial is testing

T2 FSL2 Weight Loss

Who this might be right for
Diabetes Mellitus, Type 2
Abbott Diabetes Care 43
Large-scale testing (Phase 3)Study completedNCT00997178
What this trial is testing

Diabetes and Periodontal Therapy Trial

Who this might be right for
Chronic PeriodontitisType 2 Diabetes
Stony Brook University 514
Large-scale testing (Phase 3)Study completedNCT00968708
What this trial is testing

Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Who this might be right for
Diabetes Mellitus, Type 2Acute Coronary Syndrome
Takeda 5,380
Large-scale testing (Phase 3)Study completedNCT04109547
What this trial is testing

A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 521
Large-scale testing (Phase 3)Study completedNCT06258148
What this trial is testing

TG103 Injection Monotherapy in Treatment of Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 465
Post-approval studies (Phase 4)Ended earlyNCT00283049
What this trial is testing

Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 390
Testing effectiveness (Phase 2)Study completedNCT04604548
What this trial is testing

The KHENEREXT Study

Who this might be right for
Mitochondrial DiseasesMitochondrial DNA tRNALeu(UUR) m.3243A<G MutationMaternally Inherited Diabetes and Deafness (MIDD)+2 more
Khondrion BV 11
Large-scale testing (Phase 3)Ended earlyNCT01481116
What this trial is testing

Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Takeda 2,454
Large-scale testing (Phase 3)Study completedNCT01406717
What this trial is testing

Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Sun Pharmaceutical Industries Limited 360
Early research (Phase 1)Active Not RecruitingNCT07223333
What this trial is testing

PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects

Who this might be right for
Type 2 Diabetes
AdipoPharma LLC 56
Early research (Phase 1)Study completedNCT01511185
What this trial is testing

Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 20
Post-approval studies (Phase 4)Study completedNCT01618214
What this trial is testing

Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 344
Early research (Phase 1)Study completedNCT00605449
What this trial is testing

A Drug Interaction Study Between Simvastatin and GSK376501

Who this might be right for
Type 2 Diabetes Mellitus
GlaxoSmithKline 39
Next Page